<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00362505</url>
  </required_header>
  <id_info>
    <org_study_id>L-FMAU-303</org_study_id>
    <nct_id>NCT00362505</nct_id>
  </id_info>
  <brief_title>Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials</brief_title>
  <official_title>An Open-label, Phase III Clinical Trial to Evaluate the Safety and Antiviral Activity of Clevudine in Chronic Hepatitis B Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bukwang Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bukwang Pharmaceutical</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine safety and efficacy of clevudine 10 mg qd for 24
      weeks after completion of 24-week treatment with clevudine 30 mg qd with 12 weeks follow-up
      period
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2004</start_date>
  <completion_date>March 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy:change from baseline in HBV DNA; Safety: clinically measured adverse events, abnormality of laboratory tests and abnormality of vital signs, ECG.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy:; Proportion of patients with HBV DNA below the assay Limit of Detection; Proportion of patients with HBeAg loss and/or seroconversion (HBeAg loss and HBeAb gain); Proportion of ALT normalization</measure>
  </secondary_outcome>
  <condition>Hepatitis B</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clevudine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is between 18 and 60, inclusive

          2. Patients who have completed L-FMAU-301 or L-FMAU-302 clinical trial.

          3. Patient is HBsAg positive at week 48 in L-FMAU-301 or L-FMAU-302.

          4. Patient has bilirubin levels less than 2.0 mg/dL, prothrombin time of less than 1.7
             (INR), a serum albumin level of at least 3.5 g/dL at week 48 in L-FMAU-301 or
             L-FMAU-302.

          5. Women of childbearing potential must have a negative serum (β-HCG) pregnancy test at
             screening.

          6. Patient is able to give written informed consent prior to study start and to comply
             with the study requirements.

        Exclusion Criteria:

          1. Patients with HBV DNA &lt; 4,700 copies/mL, ALT normalization and consecutive e
             seroconversion at week 40 and 48 in L-FMAU-301

          2. Patients with HBV DNA &lt; 4,700 copies/mL and ALT normalization in L-FMAU-302

          3. Patient is currently receiving antiviral, immunomodulatory or corticosteroid therapy.

          4. Patients previously treated with α-interferon, lamivudine, lobucavir, adefovir or any
             other investigational nucleoside for HBV infection.

          5. Patient has a history of ascites, variceal hemorrhage or hepatic encephalopathy.

          6. Patient is coinfected with HCV, HDV or HIV.

          7. Patient with clinical evidence of liver mass or hepatocellular carcinoma and
             α-Fetoprotein &gt; 50 ng/mL

          8. Patient is pregnant or breast-feeding.

          9. Patient is unwilling to use an &quot;effective&quot; method of contraception during the study
             and for up to 3 months after the use of study drug ceases. For males, condoms should
             be used. Females must be surgically sterile (via hysterectomy or bilateral tubal
             ligation) or post-menopausal or using at least medically acceptable barrier method of
             contraception (i.e. IUD, barrier methods with spermicide or abstinence)

         10. Patient has a clinically relevant history of abuse of alcohol or drugs.

         11. Patient has a significant gastrointestinal, renal, hepatic (decompensated),
             bronchopulmonary, biliary diseases excluding asymptomic GB stone, neurological,
             cardiovascular, oncologic or allergic disease. The patient with a benign tumor except
             for liver mass, excluded if judged by an investigator that the continuation of study
             would be interfered by the tumor.

         12. Patient has creatinine clearance less than 60mL/min as estimated by the following
             formula:

        (140-age in years) (body weight [kg])/(72)(serum creatinine [mg/dL]) [Note: multiply
        estimates by 0.85 for women]

        13.Patient whom investigator consider is not suitable in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-Suk Lee, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daesa-dong, Jung-gu</city>
        <state>Daechon</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyumg University Dongsan Medical Center</name>
      <address>
        <city>Jung-gu,</city>
        <state>Daegu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Medical Hospital</name>
      <address>
        <city>Jung-gu</city>
        <state>Daegu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Guro-gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Hak-1-dong, Dong-gu</city>
        <state>Gwangju-si</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mercy's Hospital</name>
      <address>
        <city>Bupyoung-dong, Bupyoung-gu</city>
        <state>Incheon</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Sinhung-dong, Jung-gu</city>
        <state>Incheon</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University Hospital</name>
      <address>
        <city>Iksan-City</city>
        <state>Jeonbuk</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju-city</city>
        <state>Jeonbuk</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Jongno-Gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Ilsan-gu</city>
        <state>Kyounggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Holly Family Mary's Hospital</name>
      <address>
        <city>Puch'un</city>
        <state>Kyounggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pochon CHA University Hospital</name>
      <address>
        <city>Seongnam-gu</city>
        <state>Kyounggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gil Medical Center</name>
      <address>
        <city>Incheon</city>
        <state>Namdong-Gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Ami-dong, Seo-gu</city>
        <state>Pusan</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosin Medical Center</name>
      <address>
        <city>Amnam-dong, Seo-gu</city>
        <state>Pusan</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan Paik Hospital</name>
      <address>
        <city>Gaegeum-dong</city>
        <state>Pusan</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Anam-dong, Sungbuk-ku</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KangNam St. Mary's Hospital</name>
      <address>
        <city>Banpo-dong, Seocho-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangnam Sacred Heart Hospital</name>
      <address>
        <city>Daelim-dong, Yongdeungpo-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yongdong Severance Hospital</name>
      <address>
        <city>Dogok-dong, Kangnam-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea Cancer Center Hospital</name>
      <address>
        <city>Gongneung-dong, Nowon-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soon Chun Hyang University Hospital</name>
      <address>
        <city>Hannam-dong, Yongsan-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Ilwon-dong, Songpa-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul Paik Hospital</name>
      <address>
        <city>Jeo-dong</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ehwa Womans University Mokdong Hospital</name>
      <address>
        <city>Mok-dong, Yangcheon-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul Asan Medical Center</name>
      <address>
        <city>Pungnap-dong, Kangnam-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Pyoung-dong, Chongro-gu,</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Shinchon- dong, Seodaemun-gu</city>
        <state>Seoul</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Ji-dong,, Paldal-gu</city>
        <state>Suwon</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daemyoung-dong, Nam-gu</city>
        <state>Taegu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Yungdungpo-Gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2006</study_first_submitted>
  <study_first_submitted_qc>August 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2006</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antiviral Agents</mesh_term>
    <mesh_term>Clevudine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

